Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 22.37
-0.18 (-0.80%)
At close: Mar 9, 2026
Runben Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Market Capitalization | 9,051 | 9,447 | 7,356 | - | - | - | Upgrade
|
| Market Cap Growth | -23.94% | 28.44% | - | - | - | - | Upgrade
|
| Enterprise Value | 7,922 | 9,054 | 6,808 | - | - | - | Upgrade
|
| Last Close Price | 22.37 | 23.05 | 17.66 | - | - | - | Upgrade
|
| PE Ratio | 29.47 | 31.47 | 32.54 | - | - | - | Upgrade
|
| Forward PE | 26.84 | 26.27 | 26.80 | - | - | - | Upgrade
|
| PS Ratio | 5.96 | 7.17 | 7.12 | - | - | - | Upgrade
|
| PB Ratio | 4.17 | 4.54 | 3.83 | - | - | - | Upgrade
|
| P/TBV Ratio | 4.34 | 4.66 | 3.87 | - | - | - | Upgrade
|
| P/FCF Ratio | 46.49 | 51.62 | 30.79 | - | - | - | Upgrade
|
| P/OCF Ratio | 30.40 | 36.73 | 29.13 | - | - | - | Upgrade
|
| EV/Sales Ratio | 5.22 | 6.87 | 6.59 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 22.46 | 27.62 | 25.94 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 23.86 | 29.38 | 28.06 | - | - | - | Upgrade
|
| EV/FCF Ratio | 40.69 | 49.47 | 28.50 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.01 | 0.02 | 0.04 | 0.07 | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.02 | 0.02 | 0.06 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.52 | -0.69 | -0.83 | -0.51 | -0.45 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.21 | -4.36 | -6.09 | -1.89 | -1.82 | -0.71 | Upgrade
|
| Net Debt / FCF Ratio | -5.80 | -7.82 | -6.69 | -2.96 | 18.84 | -2.82 | Upgrade
|
| Asset Turnover | 0.67 | 0.62 | 0.73 | 1.16 | 1.26 | 2.01 | Upgrade
|
| Inventory Turnover | 4.93 | 5.23 | 4.64 | 4.93 | 5.40 | 5.64 | Upgrade
|
| Quick Ratio | 9.02 | 10.58 | 16.93 | 3.97 | 3.64 | 3.72 | Upgrade
|
| Current Ratio | 12.51 | 11.63 | 18.04 | 5.28 | 4.56 | 5.85 | Upgrade
|
| Return on Equity (ROE) | 14.49% | 15.00% | 17.10% | 24.93% | 29.72% | 48.88% | Upgrade
|
| Return on Assets (ROA) | 9.17% | 9.09% | 10.66% | 15.06% | 17.69% | 30.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 31.14% | 54.09% | 60.54% | 45.44% | 45.56% | 67.89% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.20% | 14.80% | 12.60% | 24.30% | 22.90% | 42.40% | Upgrade
|
| Earnings Yield | 3.37% | 3.18% | 3.07% | - | - | - | Upgrade
|
| FCF Yield | 2.15% | 1.94% | 3.25% | - | - | - | Upgrade
|
| Dividend Yield | 2.04% | 1.78% | 0.96% | - | - | - | Upgrade
|
| Payout Ratio | 79.01% | 45.32% | - | 2.15% | 25.65% | - | Upgrade
|
| Buyback Yield / Dilution | 0.23% | -14.85% | -3.71% | -1.61% | -9.69% | -499.54% | Upgrade
|
| Total Shareholder Return | 2.26% | -13.07% | -2.75% | -1.61% | -9.69% | -499.54% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.